单孔腹腔镜下子宫内膜癌分期手术的研究进展

Research progress of laparoendoscopic single-site surgery for endometrial cancer staging

循证医学已证明腹腔镜全面分期手术可作为治疗子宫内膜癌的理想术式。经脐单孔腹腔镜成功完成子宫内膜癌分期手术的例数逐渐增多,虽然该术式与传统腹腔镜手术在术中及术后并发症、远期疗效方面差异并不明显,但单孔腹腔镜以美观程度更高、术后恢复更快的优点逐渐应用于子宫内膜癌分期手术中。由于手术难度大、学习曲线长和远期疗效缺乏大样本研究等原因,单孔腹腔镜在子宫内膜癌分期手术上尚未广泛应用。但随着医学的发展,该术式将在子宫内膜癌分期手术中占据越来越重要的地位,使更多女性从中获益。

Evidence-based medicine has proved that laparoscopic complete staging can be an ideal operation for endometrial cancer.The oncological outcomes of laparoscopic surgery for endometrial cancer are as good as those of an open approach but with many benefits.With the success of laparoendoscopic single-site surgery(LESS)in the number of stages of endometrial cancer,more and more evidence shows that there are no significant differences in intraoperative and postoperative complications and long-term efficacy between LESS and traditional laparoscopic surgery.LESS has been gradually used in staging operation of endometrial carcinoma because of its advantages of aesthetics,less postoperative complications and faster postoperative recovery.Due to the difficulty of the operation and long-time learning,and lacking large samples and long-term studies,LESS has not been widely used in the staging of endometrial carcinoma.But with advances in technology and physician practice skills,LESS will play an increasingly important role in the staging of endometrial cancer,which will benefit more and more female patients.